Axa S.A. Lexicon Pharmaceuticals, Inc. Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.99 - $2.68 $667,645 - $899,140
335,500 Added 1605.26%
356,400 $866,000
Q4 2022

Feb 14, 2023
SELL
$1.8 - $2.56 $164,282 - $233,646
-91,268 Reduced 81.37%
20,900 $39,000
Q3 2022

Feb 14, 2023
BUY
$1.94 - $3.43 $177,059 - $313,049
91,268 Added 436.69%
112,168 $269,000
Q3 2022

Nov 14, 2022
BUY
$1.94 - $3.43 $177,059 - $313,049
91,268 Added 436.69%
112,168 $269,000
Q1 2022

Feb 14, 2023
SELL
$1.95 - $3.89 $177,972 - $355,032
-91,268 Reduced 81.37%
20,900 $43,000
Q1 2022

May 13, 2022
SELL
$1.95 - $3.89 $105,885 - $211,227
-54,300 Reduced 72.21%
20,900 $44,000
Q4 2021

Feb 14, 2022
BUY
$3.81 - $6.16 $286,512 - $463,232
75,200 New
75,200 $296,000
Q3 2021

Nov 15, 2021
SELL
$3.38 - $5.35 $964,990 - $1.53 Million
-285,500 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$4.12 - $5.87 $481,216 - $685,616
-116,800 Reduced 29.03%
285,500 $1.31 Million
Q1 2021

May 14, 2021
BUY
$3.45 - $9.09 $1.17 Million - $3.09 Million
340,100 Added 546.78%
402,300 $2.36 Million
Q4 2020

Feb 12, 2021
BUY
$1.05 - $3.67 $65,310 - $228,274
62,200 New
62,200 $213,000
Q2 2020

Aug 14, 2020
SELL
$1.75 - $2.3 $33,775 - $44,390
-19,300 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$1.8 - $4.28 $207,723 - $493,920
-115,402 Reduced 85.67%
19,300 $38,000
Q4 2019

Feb 18, 2020
BUY
$3.16 - $5.15 $160,218 - $261,115
50,702 Added 60.36%
134,702 $559,000
Q3 2019

Nov 14, 2019
SELL
$1.2 - $6.66 $53,520 - $297,036
-44,600 Reduced 34.68%
84,000 $253,000
Q2 2019

Aug 13, 2019
BUY
$5.35 - $7.11 $385,200 - $511,920
72,000 Added 127.21%
128,600 $809,000
Q1 2019

May 14, 2019
BUY
$4.36 - $7.94 $246,776 - $449,404
56,600 New
56,600 $315,000

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $185M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email